| Product Code: ETC7648464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Combination Antibody Therapy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Combination Antibody Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Combination Antibody Therapy Market - Industry Life Cycle |
3.4 Israel Combination Antibody Therapy Market - Porter's Five Forces |
3.5 Israel Combination Antibody Therapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Combination Antibody Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Combination Antibody Therapy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Combination Antibody Therapy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Combination Antibody Therapy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Combination Antibody Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Israel, leading to a higher demand for combination antibody therapies. |
4.2.2 Growing investment in research and development of innovative combination antibody therapies in Israel. |
4.2.3 Favorable government regulations supporting the development and commercialization of combination antibody therapies. |
4.3 Market Restraints |
4.3.1 High costs associated with the development and production of combination antibody therapies may limit market growth. |
4.3.2 Stringent regulatory requirements for the approval of combination antibody therapies in Israel could cause delays in market entry. |
5 Israel Combination Antibody Therapy Market Trends |
6 Israel Combination Antibody Therapy Market, By Types |
6.1 Israel Combination Antibody Therapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Combination Antibody Therapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Combination Antibody Therapy Market Revenues & Volume, By Antibody/Antibody, 2021- 2031F |
6.1.4 Israel Combination Antibody Therapy Market Revenues & Volume, By Antibody-Drug Conjugates, 2021- 2031F |
6.1.5 Israel Combination Antibody Therapy Market Revenues & Volume, By Bispecific Antibodies, 2021- 2031F |
6.1.6 Israel Combination Antibody Therapy Market Revenues & Volume, By Chemotherapy-Monoclonal Antibodies, 2021- 2031F |
6.1.7 Israel Combination Antibody Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Combination Antibody Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Combination Antibody Therapy Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Israel Combination Antibody Therapy Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 Israel Combination Antibody Therapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.5 Israel Combination Antibody Therapy Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.6 Israel Combination Antibody Therapy Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.7 Israel Combination Antibody Therapy Market Revenues & Volume, By HIV, 2021- 2031F |
6.3 Israel Combination Antibody Therapy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Combination Antibody Therapy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Combination Antibody Therapy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Combination Antibody Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Combination Antibody Therapy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Combination Antibody Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Combination Antibody Therapy Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Combination Antibody Therapy Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Israel Combination Antibody Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Combination Antibody Therapy Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Combination Antibody Therapy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Combination Antibody Therapy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Israel Combination Antibody Therapy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Combination Antibody Therapy Market Import-Export Trade Statistics |
7.1 Israel Combination Antibody Therapy Market Export to Major Countries |
7.2 Israel Combination Antibody Therapy Market Imports from Major Countries |
8 Israel Combination Antibody Therapy Market Key Performance Indicators |
8.1 Number of clinical trials for combination antibody therapies conducted in Israel. |
8.2 Adoption rate of combination antibody therapies by healthcare providers in Israel. |
8.3 Number of partnerships and collaborations between Israeli biopharmaceutical companies for the development of combination antibody therapies. |
9 Israel Combination Antibody Therapy Market - Opportunity Assessment |
9.1 Israel Combination Antibody Therapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Combination Antibody Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Combination Antibody Therapy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Combination Antibody Therapy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Combination Antibody Therapy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Combination Antibody Therapy Market - Competitive Landscape |
10.1 Israel Combination Antibody Therapy Market Revenue Share, By Companies, 2024 |
10.2 Israel Combination Antibody Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here